|
|
|
Volumn 53, Issue 5, 2000, Pages 185-186
|
|
TNK-tPA: a new thrombolytic for treatment of acute myocardial infarction.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
FIBRINOGEN;
FIBRINOLYTIC AGENT;
PLASMINOGEN;
TENECTEPLASE;
TISSUE PLASMINOGEN ACTIVATOR;
TNK TISSUE PLASMINOGEN ACTIVATOR;
TNK-TISSUE PLASMINOGEN ACTIVATOR;
BLOOD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DRUG EFFECT;
DRUG SCREENING;
FIBRINOLYTIC THERAPY;
HEART INFARCTION;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
METABOLISM;
METHODOLOGY;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
SAFETY;
TREATMENT OUTCOME;
DRUG EVALUATION;
FIBRINOGEN;
FIBRINOLYTIC AGENTS;
HUMANS;
INFUSIONS, INTRAVENOUS;
MYOCARDIAL INFARCTION;
PLASMINOGEN;
RANDOMIZED CONTROLLED TRIALS;
SAFETY;
THROMBOLYTIC THERAPY;
TISSUE PLASMINOGEN ACTIVATOR;
TREATMENT OUTCOME;
|
|
EID: 0034183729
PISSN: 00383317
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (2)
|
|
References (6)
|
